Global Next Generation Sequencing Market Report

The global demand for Next Generation Sequencing Market is presumed to reach the market size of nearly USD 36.11 MN by 2028 from USD 10.24 MN in 2021 with a CAGR of 19.7% under the study period 2022 - 2028.

Next-generation sequencing (NGS) is a massively parallel sequencing method that provides scalability, ultra-high throughput, and high speed in determining the order of nucleotides throughout the entire genome. NGS has transformed the biological sciences by enabling labs to execute various applications and studies on biological systems. Next-generation sequencing (NGS) is gradually being integrated into clinical laboratory testing, analysis, and disease diagnoses in the healthcare sector worldwide. NGS has been widely employed in pharmacogenomics to speed up the drug discovery process.

Market Dynamics

The global next-generation sequencing market is being driven primarily by an increase in genome mapping initiatives, next-generation sequencing applications, increased healthcare expenditure, and technological breakthroughs in sequencing systems. One of the factors driving the growth of the next-generation sequencing market is the increasing frequency of chronic medical conditions such as cancer in medical sciences. In addition, favorable funding conditions and massive support for scientific research may provide attractive prospects for the worldwide next-generation sequencing industry to expand further. However, R&D's high costs might stifle the expansion of the next-generation sequencing market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of next generation sequencing. The growth and trends of next generation sequencing industry provide a holistic approach to this study. 

Market Segmentation

This section of the next generation sequencing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Product Type

• Instruments
• Consumables
• Services

By Type

• Whole Genome Sequencing
• Exome Sequencing
• Targeted Sequencing
• Others

By Application

• Research Application
• Clinical Application
• Others

By Technology

• Sequencing By Synthesis
• Ion Semiconductor Sequencing
• Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Next Generation Sequencing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Next Generation Sequencing Market Share by Region (Representative Graph)


The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the next generation sequencing market include Illumina, QIAGEN, Thermo Fisher Scientific, Inc., F. Hoffman-La Roche Ltd., Oxford Nanopore Technologies, Genomatix GmbH, PierianDx, DNASTAR, Inc., Eurofins GATC Biotech GmbH, Perkin Elmer, Inc., BGI, Bio-Rad Laboratories, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.